(Q46639843)

23 December 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Structural basis for antagonism by suramin of heparin binding to vaccinia complement protein (English)

1 reference

23 December 2017

1 reference

Vannakambadi K Ganesh

1

1 reference

23 December 2017

Suresh Kumar Muthuvel

2

1 reference

23 December 2017

Scott A Smith

3

1 reference

23 December 2017

Girish J Kotwal

4

1 reference

23 December 2017

Krishna H M Murthy

5

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

23 December 2017

published in

Biochemistry

1 reference

23 December 2017

volume

44

1 reference

23 December 2017

issue

32

1 reference

23 December 2017

page(s)

10757-10765

1 reference

23 December 2017

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

cites work

1 reference

20 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1107/S0907444998003254

Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1073/PNAS.0400744101

Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1016/S0092-8674(01)00214-8

Structure of the dengue virus envelope protein after membrane fusion

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

The CCP4 suite: programs for protein crystallography

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Angiogenesis: regulators and clinical applications

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

The polysulfonated compound suramin blocks adsorption and lateral difusion of herpes simplex virus type-1 in vero cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Poxviral mimicry of complement and chemokine system components: what's the end game?

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Complement evasion strategies of microorganisms

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Structure of a heparin-linked biologically active dimer of fibroblast growth factor

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Role of heparan sulfate in fibroblast growth factor signalling: a structural view

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

NMR studies of a viral protein that mimics the regulators of complement activation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Nature of the interaction of growth factors with suramin

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Phase II trial of suramin in patients with metastatic renal cell carcinoma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Conformation of the trypanocidal pharmaceutical suramin in its free and bound forms: transferred nuclear overhauser studies

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Herpes simplex virus glycoprotein D bound to the human receptor HveA

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Synthesis and binding mode of heterocyclic analogues of suramin inhibiting the human basic fibroblast growth factor

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel [...]

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity: crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalene sulfonate

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

FGFs, heparan sulfate and FGFRs: complex interactions essential for development

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Miscellaneous algorithms for density modification

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Suramin blocks hepatitis C binding to human hepatoma cells in vitro

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Solution structure of acidic fibroblast growth factor bound to 1,3, 6-naphthalenetrisulfonate: a minimal model for the anti-tumoral action of suramins and suradistas

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Fosmidomycin for the treatment of malaria

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Inhibition of the complement cascade by the major secretory protein of vaccinia virus

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Fibroblast growth factors and their inhibitors

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Suramin is an active site-directed, reversible, and tight-binding inhibitor of protein-tyrosine phosphatases

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Structure and distribution of modules in extracellular proteins

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Improved methods for building protein models in electron density maps and the location of errors in these models

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Crystallization and preliminary X-ray diffraction analysis of suramin, a highly charged polysulfonated napthylurea, complexed with a myotoxic PLA2 from Bothrops asper venom.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Pushing the boundaries of molecular replacement with maximum likelihood

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Processing of X-ray diffraction data collected in oscillation mode

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Suramin's development: what did we learn?

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

A ligand-binding pocket in the dengue virus envelope glycoprotein

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Suramin in non-small cell lung cancer and advanced breast cancer. Two parallel phase II studies

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1021/BI050401X

Identifiers

DOI

10.1021/BI050401X

1 reference

23 December 2017

1 reference

23 December 2017